IBDEI1BF ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23298,1,5,0)
 ;;=5^Generalized Pain
 ;;^UTILITY(U,$J,358.3,23298,2)
 ;;=^334163
 ;;^UTILITY(U,$J,358.3,23299,0)
 ;;=607.9^^125^1404^30
 ;;^UTILITY(U,$J,358.3,23299,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23299,1,4,0)
 ;;=4^607.9
 ;;^UTILITY(U,$J,358.3,23299,1,5,0)
 ;;=5^Penile Pain
 ;;^UTILITY(U,$J,358.3,23299,2)
 ;;=^270442
 ;;^UTILITY(U,$J,358.3,23300,0)
 ;;=608.9^^125^1404^32
 ;;^UTILITY(U,$J,358.3,23300,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23300,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,23300,1,5,0)
 ;;=5^Scrotal Pain
 ;;^UTILITY(U,$J,358.3,23300,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,23301,0)
 ;;=V68.1^^125^1405^4
 ;;^UTILITY(U,$J,358.3,23301,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23301,1,4,0)
 ;;=4^V68.1
 ;;^UTILITY(U,$J,358.3,23301,1,5,0)
 ;;=5^Rx Refill (Also mark Condition)
 ;;^UTILITY(U,$J,358.3,23301,2)
 ;;=RX Refill (also mark Condition)^295585
 ;;^UTILITY(U,$J,358.3,23302,0)
 ;;=V68.81^^125^1405^6
 ;;^UTILITY(U,$J,358.3,23302,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23302,1,4,0)
 ;;=4^V68.81
 ;;^UTILITY(U,$J,358.3,23302,1,5,0)
 ;;=5^Transfer of Care (Also Mark Dx)
 ;;^UTILITY(U,$J,358.3,23302,2)
 ;;=Transfer of Care ^295587
 ;;^UTILITY(U,$J,358.3,23303,0)
 ;;=V58.83^^125^1405^5
 ;;^UTILITY(U,$J,358.3,23303,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23303,1,4,0)
 ;;=4^V58.83
 ;;^UTILITY(U,$J,358.3,23303,1,5,0)
 ;;=5^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,23303,2)
 ;;=Encounter for Therapeutic Drug Monitoring^322076
 ;;^UTILITY(U,$J,358.3,23304,0)
 ;;=V65.19^^125^1405^3
 ;;^UTILITY(U,$J,358.3,23304,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23304,1,4,0)
 ;;=4^V65.19
 ;;^UTILITY(U,$J,358.3,23304,1,5,0)
 ;;=5^Person Consulting on Behalf of Pt
 ;;^UTILITY(U,$J,358.3,23304,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,23305,0)
 ;;=V60.89^^125^1405^1
 ;;^UTILITY(U,$J,358.3,23305,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23305,1,4,0)
 ;;=4^V60.89
 ;;^UTILITY(U,$J,358.3,23305,1,5,0)
 ;;=5^Housing/Economic Circumstances
 ;;^UTILITY(U,$J,358.3,23305,2)
 ;;=^295545
 ;;^UTILITY(U,$J,358.3,23306,0)
 ;;=V68.09^^125^1405^2
 ;;^UTILITY(U,$J,358.3,23306,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23306,1,4,0)
 ;;=4^V68.09
 ;;^UTILITY(U,$J,358.3,23306,1,5,0)
 ;;=5^Issue of Medical Certificate
 ;;^UTILITY(U,$J,358.3,23306,2)
 ;;=^335321
 ;;^UTILITY(U,$J,358.3,23307,0)
 ;;=309.0^^125^1406^1
 ;;^UTILITY(U,$J,358.3,23307,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23307,1,4,0)
 ;;=4^309.0
 ;;^UTILITY(U,$J,358.3,23307,1,5,0)
 ;;=5^Adjustment Disorder
 ;;^UTILITY(U,$J,358.3,23307,2)
 ;;=^331948
 ;;^UTILITY(U,$J,358.3,23308,0)
 ;;=305.00^^125^1406^3
 ;;^UTILITY(U,$J,358.3,23308,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23308,1,4,0)
 ;;=4^305.00
 ;;^UTILITY(U,$J,358.3,23308,1,5,0)
 ;;=5^Alcohol Abuse-Unspec
 ;;^UTILITY(U,$J,358.3,23308,2)
 ;;=^268227
 ;;^UTILITY(U,$J,358.3,23309,0)
 ;;=305.03^^125^1406^2
 ;;^UTILITY(U,$J,358.3,23309,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23309,1,4,0)
 ;;=4^305.03
 ;;^UTILITY(U,$J,358.3,23309,1,5,0)
 ;;=5^Alcohol Abuse-In Remission
 ;;^UTILITY(U,$J,358.3,23309,2)
 ;;=^268230
 ;;^UTILITY(U,$J,358.3,23310,0)
 ;;=477.9^^125^1406^4
 ;;^UTILITY(U,$J,358.3,23310,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23310,1,4,0)
 ;;=4^477.9
 ;;^UTILITY(U,$J,358.3,23310,1,5,0)
 ;;=5^Allergic Rhinitis NOS
 ;;^UTILITY(U,$J,358.3,23310,2)
 ;;=^4955
 ;;^UTILITY(U,$J,358.3,23311,0)
 ;;=285.9^^125^1406^5
 ;;^UTILITY(U,$J,358.3,23311,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23311,1,4,0)
 ;;=4^285.9
 ;;^UTILITY(U,$J,358.3,23311,1,5,0)
 ;;=5^Anemia NOS
 ;;
 ;;$END ROU IBDEI1BF
